[PDF] Top 20 Programmed cell death in amyotrophic lateral sclerosis

... Amyotrophic lateral sclerosis (ALS) is a relentless fatal paralytic disorder confined to the voluntary motor system ...causing death among the vast majority of ALS patients with- in 2–5 years ... See full document

... the cell viability, increase the formation of ubiquitinated aggregates and enhance the apoptosis in primary motor neuron cultures ...neuron death in- duced by this mutation can be mediated by both ... See full document

... Pro-inflammatory cytokines have gained notoriety for their role in triggering and propagating inflammation- mediated neurotoxicity [40]. The up-regulation of IL-6, IFN-γ, and TNF-α in both mRNA as well as protein levels ... See full document

... CSF samples from controls (n = 10) and ALS patients (n = 10) were pooled individually and used for iTRAQ based quantitative proteomic comparison by mass spec- trometry (Figure 4). Samples were centrifuged at 10,000 rpm ... See full document

... 33. Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, Wimbish JR, Waite LL, Jones AL, Carulli JP, Day-Williams AG, ... See full document

... Amyotrophic lateral sclerosis (ALS) is a progressive and almost always devastating neurodegenerative ...final death, typically from respiratory ... See full document

... These cell types are arranged in well-ordered wiring patterns that maintain the complex functions of cortical regions by their unique placement, connections and firing properties (Kubota ...if cell position ... See full document

... In populations of European origin, only 5–10% of patients with ALS report a family history of the disease (figure 2). It seems likely that there is a complex set of genetic determinants, each with potentially small but ... See full document

... The use of respiratory measures to predict the time to ventilation and/or death has also been studied (63,69,71,73). For example, the recent retrospective analysis of placebo-treated patients from EMPOWER, ... See full document

... of amyotrophic lateral sclerosis (ALS) have not been fully elucidated, it has been suggested that riluzole acts by the inhi- bition of glutamate-related processes, which are thought to play a role in ... See full document

... de Carvalho and Swash (2006) proposed that the inclusion of patients with rapid progression rates may shorten clinical trials. Nevertheless, one has to keep in mind that certain subtypes might respond differently to ... See full document

... Amyotrophic lateral sclerosis (ALS) is a nervous system disease that attacks nerve cells called neurons in your brain and spinal cord. The neurons transmit messages from your brain and spinal cord to ... See full document

... their cell replacement capacity but also for their ability to respond to the needs of the host via secretion of supportive factors and modulation of immune ...for cell therapy for ... See full document

... with Amyotrophic Lateral Sclerosis (ALS) or Progressive Muscular Atrophy (PMA) face stressful demands due to severe impairments and prospect of early death of the patients they care ... See full document

... This short review has attempted to summarize the depth of study that has been carried out using transcriptomic technology to examine the gene expression changes that can be identified in comparisons of ALS tissue and ... See full document

... dysfunction, dysarthria may arise from either LMN pathology or pseudobulbar palsy from UMN disorder, leading to slow slurred speech or a nasal quality. On examining the cranial nerves, the jaw jerk may be brisk, ... See full document

... of Amyotrophic Lateral Sclerosis (ALS) remains ...for amyotrophic lateral sclerosis (ALS), and thus antioxidants such as UA that could reduce oxidative stress might be beneficial ... See full document

... via cell to cell transmis- sion ...this cell to cell transmission appears not to be infectious, at least for AD, PD and FTLD-Tau [63], but rather may regulate the spatial distribution and ... See full document

... Demographic, clinical, and neuropsychological data for the patient and control groups were compared with a χ 2 test for categorical data (or Fisher exact test when expected cell fre- quencies fell below 5) or ... See full document

... However a 2014 systematic review and meta-analysis of 37 studies again concluded that there was Armon class A evidence that physical activity was not a risk factor for ALS, but for occup[r] ... See full document